The deal could be worth $380 million including royalties and milestone payments.
Caesarea-based Remon Medical Technologies, developer of intra and inter-body wireless communication for early warning systems of heart failure, is expected to sign a final agreement for its sale to medical devices giant Boston Scientific.
The company develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. The company's technology utilizes wireless communications to exchange energy and data with minute devices placed deep inside the body.
The company will receive an initial payment of $80 million, with later payments from agreed upon milestones and royalties, which are expected to reach $300 million.
The parties declined to comment on the report, and the future of the Israeli company and its dozens of employees remains unclear.
According to IVC, Remon Medical had already raised $40-50 million from various other funds including Ofer Hi Tech Ltd., Biomedical, US fund Polaris Venture Partners, and others.
Remon, which was founded in 1997, developed a method for increasing the effectiveness of ultra-sound transmission by three orders of magnitude, meaning 1000 times.

Published by: Globes
www.globes.co.il
Gali Weinreb
21/06/2007
 

Medical device co EZsurgical raises 1,975,000$. The company’s first product is designed to manipulate and separate soft tissue during laparoscopy.

Naiot Venture Accelerator graduate start-up EZsurgical Ltd. has raised $1,975,000 million in a follow-on round led by Ofer Hi Tech Ltd. and the Itochu Corporation. The company’s first product is designed to manipulate and separate soft tissue during surgery, in order to prevent it from interfering with the tissue being treated and prevent damage during the procedure.

The company’s flagship product is designed to separate tissues during laparoscopic surgical procedures of the abdomen, which involve small incisions through which the surgical tools are inserted. The device is inserted through the incision and acts as a kind of wall separating the healthy tissue from the subject of the procedure.

Angioslide has completed an $8.25 million fund raising round.
The round was led by Agate Medical Investments. Existing investors Ofer Hi-Tech Investments, owner of the Naiot incubator, and D Partners of Shlomo Dovrat’s Viola Group, also took part in the round.

Enzymotec hosted guests from around the globe at the opening of its new 200,000-square-foot facility, located in the Sagi 2000 industry area of northern Israel.

Checkmarx Ltd. engaged in Source Code Analysis (SCA) Technologies, has completed a capital raising round of 2.5M$ From the Ofer Hi-Tech Group.

 

The company, founded in 2006, has developed the Checkmarx CxSuite®, a powerful Source Code Analysis solution designed for identifying, tracking and fixing technical and logical security flaws from the root.

 

Chckmarx CEO, Emanuel Ben-Zaken commented that current financial climate has only increased the demand for the company's solution, as consumer demands, as well new regulations, require that source code analysis for new software purchased, will be at a higher level than ever before.

Israeli lipid specialist, Enzymotec, has marked the opening of a new plant with an inauguration ceremony. Among the attendees was Israeli president, Shimon Peres.

 

President Peres praised the company, commenting: “In Israel we are not trying to be champions, we are trying to be pioneers. Even an important thing like food can be harmful to the body, however, Enzymotec  turns food into a cure.”

 

The facility has new production lines, research laboratories and houses the company’s main offices.

Towards the TWS 2009 event, The ten most promising Israeli StartUps have been announced.   One of the StartUps is a Naiot Portfolio Web Application company, CmyCasa.      

Cmycasa is a first of its kind online catalog for furniture and home appliances. With Cmycasa users are able to visualize in stunning photo-realistic 3D what their new home will look like once furnished to their taste.  

 

All ten companies were chosen by a world-class panel of judges, ranging from über-Angel investor Ron Conway, to legendary ICQ founder and current founder and CTO of Dotomi, Yair Goldfinger.  

 

TWS 2009 is an annual event organized by Israeli financial newspaper Globes, and leading Israeli startup blog, the.co.ils with its founder Yaron Orenstein, and partnered by TechCrunch, and Seqouya Capital.

The event is aimed at showcasing ten promising Israeli startups and to serve as a networking platform for the individuals and companies leading Israel’s startup scene.